Mycoplasma pneumoniae is the most common bacterial strain causing atypical pneumonia in children and adolencents. Although it is known to cause mild symptoms, it can also cause severe pulmonary or extrapulmonary complications in rare cases. Necrotizing pneumonia (NP) is often reported as a complication of Streptococcus pneumoniae and is very rarely caused by M. pneumoniae. We report a case in which a 5-year-old boy was diagnosed with lobar pneumonia with symptoms that aggravated even with macrolide antibiotic treatment. Anti-mycoplasma pneumoniae Ig-M test yielded high values, and direct polymerase chain reaction results were also positive. NP caused by M. pneumoniae was confirmed on computed tomography.
Mycoplasma pneumoniae is the most common strain of bacteria causing lower respiratory infections as well as community-acquired pneumonia (CAP) in school-aged children and adolescents.
In particular, it accounts for 10% ~ 40% of community-acquired pneumonia cases in children and adolescents. 1 M. pneumoniae causes mild or moderate pneumonia, which often improves without sequelae. However, it can also progress to life-threatening, severe pneumonia, such as fulminant or necrotizing pneumonia (NP), bronchiolitis obliterans, acute respiratory distress syn-drome, chronic interstitial fibrosis, and lung abscesses, and can cause extrapulmonary complications. 1, 2 Worldwide, the incidence of macrolide-resistant M. pneumoniae pneumonia has been increased recently, and complications associated with it have also been reported. 3 NP is typically caused by infections with Streptococcus pneumoniae, and other organisms, but cases caused by M. pneumoniae are very rare. 4 Herein, we report a case of NP caused by M. pneumoniae that required quinolone antibiotics and systemic steroid without surgical intervention. And we review the appropriate methods of steroid use, treatments and diagnosis based on the relevant literature.
CASE
A 5-year-old boy who was otherwise healthy and had no underlying disease was diagnosed with pneumonia and hospitalized for 10 days for treatment at a local clinic. Although the patient was treated with clarithromycin, one of a macrolide antibiotic, for 10 days, his fever and dry coughs worsened, and aggravation of pneumonia was also confirmed on chest x-ray. The patient did not exhibit hemoptysis. He did not have any gastrointestinal symptom, chest pain, rash, or arthralgia.
The patient had not travelled recently. His past medical history, social history, or family history did not show any particular things to remark.
According to physical examination conducted at admission, the body temperature was 37.8℃, the heart rate was 128/min, and the breathing rate was 22/min. Oxygen saturation was 97% in atmosphere. The patient showed acute ill-looking appearance. Although lower left lung sounds were diminished compared with the right side, rale was not noted. The patient had normal heart sounds, and no heart murmur was detected.
According to the blood test conducted at admission, the patient had a white blood cell count of 20,010/mm 3 (neutrophil 85%, lymphocyte 8%), a hemoglobin count of 10.8 g/dL, and a platelet count of 242,000/μL. In addition, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) were mildly elevated.
C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were also elevated to 169.18 mg/dL, and 19 mm/h, respectively ( Table 1) Fig. 2A, 2B) . Therefore, the antibiotic was changed to 10 mg/kg/day (divided into 2 doses/day) of tosufloxacin, a quinolone antibiotic. 6 After 15 days of administration of methylprednisolone, the dose was gradually tapered for 7 days. Tosufloxacin was administered for 10 days. Severe M. pneumoniae pneumonia may occasionally be associated with changes in lung function and chronic lung pneumoniae pneumonia should be suspected. 9 Quinolone antibiotics can be used to treat Macrolide-resistent M. pneumoniae pneumonia. 2, 9, 14 Steroids can also be used if macrolide-resistent M. pneumoniae pneumonia progresses to severe pneumonia 8, 9, 14 Clinical experiences and animal model suggested that the use of both antimicrobial therapy and corticosteroids is important to improve the outcome of severe M. pneumoniae pneumonia. 2, 8, 9, 11 Therefore, we had used systemic steroids for a short period of time.
Serum interleukin (IL)-18 is believed to be associated with the severity of pneumonia because its level increases particularly in the acute phase and it induces the expression of various cytokines. 15 Thus, The serum IL-18 level was thought to be a useful as a predictor of refractory or severe M. pneumoniae pneumonia. The serum levels of IL-18 correlated significantly with those of lactate dehydrogenase (LDH). 11, 15 In this case, patient was treated with clarithromycin, a widely used macrolide antibiotic, for 10 days, but the fever and respiratory symptoms persisted after the treatment. The serum LDH level was elevated by more than 400 U/L. Therefore, we suspected macrolide-resistent M. pneumoniae pneumonia and changed the antibiotics to tosufloxacin, which was continued for 
